Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:48 AM
Ignite Modification Date:
2025-12-25 @ 3:48 AM
NCT ID:
NCT04537702
Eligibility Criteria:
Inclusion Criteria:
* Either a) pathologically confirmed diagnosis of high-grade epithelial ovarian, fallopian or peritoneal cancer via biopsy or surgical pathology or b) cytologic diagnosis consistent with high-grade epithelial ovarian cancer.
* Presenting to Duke gynecologic oncology clinic or collaborating institution for first outpatient visit following pathologic or cytologic diagnosis. If logistic constraints prevent the patient from being enrolled at her initial visit, she will be eligible for enrollment up to initiation of her fifth cycle of chemotherapy.
Exclusion Criteria:
* Known family or personal history of an inherited cancer susceptibility mutation
* Previously received genetic counseling or testing for an inherited cancer susceptibility mutation
* Insurance provided by an insurance company that requires face-to-face genetic consultation prior to testing
* Unable to read or speak English as study design includes video assisted educational materials in English
* Blind or deaf as study design includes video assisted educational materials in English
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT04537702
Study Brief:
Protocol Section:
NCT04537702